EP0186681A1 - Hautpflegemittel und verfahren zu seiner herstellung - Google Patents
Hautpflegemittel und verfahren zu seiner herstellungInfo
- Publication number
- EP0186681A1 EP0186681A1 EP19850902628 EP85902628A EP0186681A1 EP 0186681 A1 EP0186681 A1 EP 0186681A1 EP 19850902628 EP19850902628 EP 19850902628 EP 85902628 A EP85902628 A EP 85902628A EP 0186681 A1 EP0186681 A1 EP 0186681A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- mass
- blood plasma
- skin care
- plasma extract
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 16
- 210000002381 plasma Anatomy 0.000 claims abstract description 81
- 239000000284 extract Substances 0.000 claims abstract description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 42
- 150000003839 salts Chemical class 0.000 claims abstract description 19
- 239000006071 cream Substances 0.000 claims abstract description 18
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 239000003755 preservative agent Substances 0.000 claims abstract description 12
- 210000004369 blood Anatomy 0.000 claims abstract description 9
- 239000008280 blood Substances 0.000 claims abstract description 9
- 239000000654 additive Substances 0.000 claims abstract description 7
- 235000013336 milk Nutrition 0.000 claims abstract description 7
- 239000008267 milk Substances 0.000 claims abstract description 7
- 210000004080 milk Anatomy 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 6
- 239000000839 emulsion Substances 0.000 claims abstract description 5
- 239000006260 foam Substances 0.000 claims abstract description 4
- 230000037072 sun protection Effects 0.000 claims abstract description 4
- 239000006210 lotion Substances 0.000 claims abstract description 3
- 239000002304 perfume Substances 0.000 claims abstract 3
- 239000012071 phase Substances 0.000 claims description 67
- 239000000047 product Substances 0.000 claims description 35
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 23
- 239000003205 fragrance Substances 0.000 claims description 18
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 17
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000003995 emulsifying agent Substances 0.000 claims description 12
- 230000002335 preservative effect Effects 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 8
- 235000013772 propylene glycol Nutrition 0.000 claims description 8
- 239000000516 sunscreening agent Substances 0.000 claims description 7
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000005662 Paraffin oil Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000000475 sunscreen effect Effects 0.000 claims description 6
- 230000000887 hydrating effect Effects 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- 239000005995 Aluminium silicate Substances 0.000 claims description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 235000012211 aluminium silicate Nutrition 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims description 4
- 239000007844 bleaching agent Substances 0.000 claims description 4
- 235000019441 ethanol Nutrition 0.000 claims description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004408 titanium dioxide Substances 0.000 claims description 4
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- 240000003538 Chamaemelum nobile Species 0.000 claims description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 2
- 239000011703 D-panthenol Substances 0.000 claims description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- 235000004866 D-panthenol Nutrition 0.000 claims description 2
- 239000004166 Lanolin Substances 0.000 claims description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 claims description 2
- 239000003146 anticoagulant agent Substances 0.000 claims description 2
- 229940127219 anticoagulant drug Drugs 0.000 claims description 2
- 229960000541 cetyl alcohol Drugs 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 229960003949 dexpanthenol Drugs 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical class C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 229940039717 lanolin Drugs 0.000 claims description 2
- 235000019388 lanolin Nutrition 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 229920001083 polybutene Polymers 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 239000003380 propellant Substances 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 238000010792 warming Methods 0.000 claims description 2
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 238000000108 ultra-filtration Methods 0.000 abstract description 7
- 239000000969 carrier Substances 0.000 abstract description 4
- 239000003223 protective agent Substances 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- 239000011814 protection agent Substances 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 14
- 229940024606 amino acid Drugs 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 11
- 108010049003 Fibrinogen Proteins 0.000 description 8
- 102000008946 Fibrinogen Human genes 0.000 description 8
- 229940012952 fibrinogen Drugs 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 102000016942 Elastin Human genes 0.000 description 7
- 108010014258 Elastin Proteins 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 229920002549 elastin Polymers 0.000 description 7
- 238000001035 drying Methods 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 108010044091 Globulins Proteins 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 102000034238 globular proteins Human genes 0.000 description 2
- 108091005896 globular proteins Proteins 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 108010045362 Serum Globulins Proteins 0.000 description 1
- 102000005686 Serum Globulins Human genes 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/983—Blood, e.g. plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Definitions
- the invention relates to a skin care product which can be used in the different areas of skin care together with the known carrier, additive, fragrance, preservative and optionally protective and coloring agents which are customary for this.
- the skin care product according to the invention can therefore be used as a bath product, i.e. as a cream bath, shower bath (gel), body care milk, also in the form of creams, i.e. as a face cream, night cream, face pack (mask), also as sunscreen such as sun milk, sunscreen foam, after-sun cream and also as lip gloss or eyeshadow, but numerous other manifestations are conceivable in addition to the forms listed here.
- the different skin care products have the non-secondary task of nourishing and protecting the skin, restoring its elasticity and giving it its natural condition. This is the main purpose for cream products, and a complementary function for bathing products or sunscreens.
- human skin has a protective film which is in the form of a suspension or an emulsion.
- This protective film has a pH of 4.5-5.5, and is therefore also called the protective acid mantle of the skin. It consists of sebum, water, various amino acids, proteins and minerals. When cleaning the skin, this protective coat can be damaged and dry out, so it must be returned to its natural state.
- the preparations produced to nourish the skin, to preserve or restore its natural state contain, as active ingredients, extracts of vegetable or animal origin, which are rich in proteins and amino acids and therefore exert an advantageous influence on the skin.
- the object of the invention is to meet this real need satisfy and accordingly to create a novel skin care product and a process for its preparation.
- the invention is based on the knowledge that, among the natural active ingredients, all those that make it possible to achieve the stated goal are contained in the blood due to its protein and amino acid composition.
- the use of the hat in its natural form for cosmetic purposes is hampered by numerous circumstances, including its tendency to clot and spoil, its color, etc.
- the industrial use of blood from slaughterhouses is well known. It is treated with an anticoagulator and then separated into thick blood and blood plasma in the separator.
- the blood plasma is mainly used in the food industry. It mainly contains globulins, lipoproteins and fibrinogen as protein groups. In its natural form, the blood plasma seems unsuitable for use as an active ingredient due to its high water content and its perishability.
- a blood plasma extract which can be used according to the invention as an active ingredient for skin care products can be obtained from blood plasma by drying.
- the blood plasma extract contains a relatively large amount of salt, since the salt concentration increases with drying and concentration as the water emerges.
- the composition of the blood plasma, the dried blood plasma and the content of essential amino acids in the blood plasma are given below (Grant, R.A .: Applied protein chemistry, Applied Sei. Publishers, Ltd., London, 1980).
- the protein content of the dried blood plasma is therefore 71.9% and that of the blood plasma is only 7.9%. This almost tenfold amount results from the considerable reduction in the water content.
- the 16.5% salt contained in the dried blood plasma is an obstacle for most cosmetic applications, primarily the salts originating from the anticoagulator pose a danger. These are different phosphates that coagulate the proteins on the surface of the skin.
- the high salt content has a dehydrating effect, dries out the skin and can also irritate it.
- the blood plasma extract can therefore only be used in small quantities for cosmetic purposes. The thickening of the blood plasma, however, cannot be done only by drying.
- ultrafiltration With the technology referred to in the industry as ultrafiltration, particles with a molecular weight of only 16000-18000 can be separated from the liquid phase.
- the molar mass of the valuable proteins and amino acids contained in the blood plasma is above this range, and they can therefore be separated from the liquid phase by ultrafiltration.
- Ultrafiltration not only removes the liquid, but also the salts dissolved in it, ie the extract has a much lower salt content.
- the blood plasma thickened by ultrafiltration only has a salt content of about 4.1%, of which only about 2.5% are residues originating from the anticoagulator. This amount of salt can already be described as negligible.
- the invention relates to a skin care product which can be used in different areas of skin care and which contains carriers, additives, fragrances and other substances which are characteristic of these areas.
- the skin care agent according to the invention contains, as an active ingredient, blood plasma extract obtained from slaughterhouse blood in an amount of at least 0.3% by mass and at most 6% by mass.
- the advantages of the protein components contained in the blood plasma also compensate for the possible disadvantages of the salt content contained in the dried blood plasma extract.
- Much more favorable results are achieved, however, if the salt concentration in the blood plasma extract is at most 6%, in particular below 4.2%. This concentration can only be achieved by ultrafiltration. If the blood plasma extract is not broken down into fractions, it retains its original composition and the residues from the anticoagulant added to the slaughterhouse blood account for a maximum of 60% of the permissible salt content.
- the protein and amino acid composition of the blood plasma extract corresponds to that of the blood plasma and the protein concentration in the extract is at least 60%.
- serum albumin and serum globulins in particular have the property of adding water tie; they are adsorbed on the skin surface and protect the skin from drying out, have a hydrating effect.
- the gamma globulin which can only be found in the blood plasma, is known to be the antidote to acute diseases, it increases the resistance of the organism.
- the lipoproteins are suitable for the stabilization of water / oil systems and their presence in the skin care products which represent emulsion systems has a stabilizing effect.
- the lipoproteins also contain fat on their surface, so they supplement the fat content of the skin.
- the amino acid composition of the fibrinogen contained in the plasma is more favorable compared to that of other biologically active compounds (collagen, elastin).
- the threonine content of the fibrinogen is three and six times as high, and the leucine and isoleucine content is about three times that of the collagen.
- Fibrinogen contains five times as much tyrosine and more than twice as much lysine as collagen, and its lysine content is sixteen times that of elastin.
- the arginine content of the blood plasma is six times that of the elastin. Tryptophan is not found at all in collagen and elastin, but in significant amounts in fibrinogen.
- Collagen contains no cystine, and elastin contains only one seventh of the cystine content of fibrinogen.
- the other important sulfur-containing amino acid, methionine is only present in trace amounts in elastin, and collagen also contains only a quarter of the methionine content of fibrinogen.
- Collagen and elastin are considered to be extremely advantageous as active ingredients in skin care products.
- the comparative figures given therefore show some of the advantages that result from the use of blood plasma.
- Example 1 Two phases are prepared for the production of a cream bath. The first consists of sodium lauryl ether sulfate at 50% by mass, 1% by mass of fragrances and 1% by mass of refatting agent, the second from 42.5% by mass of distilled water, 3% by mass of sodium chloride and 3% by mass of blood plasma extract. The two phases are stirred separately until everything has dissolved, and then the first phase is dissolved in the second phase.
- Example 2 Two phases are prepared for the production of a cream bath. The first consists of sodium lauryl ether sulfate at 50% by mass, 1% by mass of fragrances and 1% by mass of refatting agent, the second from 42.5% by mass of distilled water, 3% by mass of sodium chloride and 3% by mass of blood plasma extract. The two phases are stirred separately until everything has dissolved, and then the first phase is dissolved in the second phase.
- Example 2
- a shower bath has the following composition: 40% by weight of surface-active substance, preferably sodium lauryl ether sulfate, 20% by weight of betaine derivative, 5% by weight of fatty acid diethanolamide, 0.5% by weight of fragrances, 0.5% by weight of preservative, 2% by weight of blood plasma extract and 32% by weight Water.
- surface-active substance preferably sodium lauryl ether sulfate, 20% by weight of betaine derivative, 5% by weight of fatty acid diethanolamide, 0.5% by weight of fragrances, 0.5% by weight of preservative, 2% by weight of blood plasma extract and 32% by weight Water.
- the first phase contains 6 mass% emulsifier, 3 mass% isopropyl myristate, 8 mass% paraffin oil, 0.5 mass% cetyl alcohol and 2 mass% light protection substance against UV radiation.
- the second phase contains 1 mass% of water-soluble lipid-replenishing agent, 1 mass% of blood plasma extract, 0.4 mass% of propylene glycol and 5 mass% of preservative as well as 73.1 mass% of distilled water.
- the blood plasma extract is swollen in water, then the components of the second phase are added. Both phases are heated separately to 70-75 ° C, then the first phase is added to the second phase with vigorous stirring. With slow stirring, the mixture is cooled to 30-35 ° C. and fragrance is added in an amount of 0.2% by mass.
- Example 4 Sun protection foam is also produced from two phases.
- the first phase contains 10 mass% emulsifier, 2.5 mass% fat phase component, and the second phase contains 70.7 mass% distilled water, 1 mass% blood plasma extract, 5 mass% propylene glycol and 0.3 mass% preservative.
- the bluplasma extract is first swelled in water and then the other components of the second phase are added.
- the two phases are heated separately to about 75 ° C.
- the first phase is poured into the second and the system is emulsified. It is stirred more slowly and at a temperature of about 40 ° C 0.5% by weight of fragrances are added. 85% of the mass obtained are filled together with 15% propellant gas in spray containers.
- the first phase consists of 15% by mass of ethyl alcohol, 0.5% by mass of fragrances and 3.5% by mass of refatting agent and the second phase consists of 67% by mass of distilled water, 1% by weight of D-panthenol and 1% by mass % Blood plasma extract, 2 mass% hydrating additives, 5 mass% of an extract pulling the pores together and 5 mass% chamomile distillate.
- the phases are mixed and homogenized.
- Example 6 Personal care milk is also prepared in two phases.
- the first phase consists of 7.5 mass% emulsifier and 45 mass% paraffin oil
- the second phase consists of 46.75 mass% distilled water and 0.5 mass% blood plasma extract.
- the two phases are heated separately to 70 ° C and an emulsion is prepared by pouring the second phase into the first. With slow stirring, the mixture is cooled back to 30-35 ° C. and then fragrance is added in an amount of 0.25% by mass.
- Example 7
- the first phase contains 25 mass% emulsifier, 5 mass% isopropyl myristate and 8 mass% paraffin oil and the second phase 48.5 mass% distilled water, 5.5 mass5 propylene glycol, 2 mass% hydrating additives, 0.5 mass% magnesium sulfate and 5 Mass% blood plasma extract.
- the phases are heated separately to 70 ° C, then the second phase is poured into the first with rapid stirring and the mixture is cooled to about 35 ° C with slow stirring. At this temperature, 0.5% by mass of fragrances are added.
- a face pack is prepared according to the following recipe: 6 mass% stearin, 0.3 mass% triethanolamine, 5 mass% bleach, 0.5 mass% blood plasma extract, 71.2 mass% water, 15 mass% kaolin and 2 mass% Titanium dioxide.
- the blood plasma extract and the bleach are dissolved in part of the water with stirring.
- the stearin is melted at 75 ° C and added together with the mixture of the remaining water with the triethanolamine with vigorous stirring at 80 ° C.
- the mixture is cooled to 35 ° C. with stirring, and kaolin and titanium dioxide are added at this temperature.
- a face pack is prepared according to the following recipe: 5 mass% fat phase component, 5 mass% 86% glycerol, 23 mass% 96% ethyl alcohol, 2 mass5 blood plasma extract, 0.1 mass% triethanolamine, 0.2 mass% fragrance and 64.7 Mass% consistency. In the latter, the blood plasma extract is dissolved and the other substances are added.
- a face cream is prepared in two phases.
- the first phase contains 16 mass% fat phase component and 13 mass% emulsifier, while the second phase consists of 5 mass% 1,2-propylene glycol, 61 mass% water and 5 mass% blood plasma extract.
- the pH of the aqueous phase is adjusted to 3.7-6.5. Both phases are heated to 75-80 ° C and then mixed together.
- Example 11 From 30% by mass of lanolin, 51% by mass of polybutene, 4% by mass
- Paraffin wax, 9% by mass of dye, 5% by mass of blood plasma extract and 1% by mass of flavoring agents is used to produce lip gloss by melting the materials at 80-90 ° C, homogenizing them and then filling them into cans at 50-60 ° C.
- Eye shadow is prepared from two phases.
- the first contains 10% by mass of stearic acid. 10 mass% iron oxide, 3.3 mass% isopropyl myristate, 0.2 mass% preservative and 2 mass% emulsifier
- the second consists of 3.3 mass% triethanolamine, 10 mass% magnesium aluminum silicate, 7.5 mass% film former, 2.5 Mass% 1,2-propanediol, 0.2 mass% preservative, the rest is ion-free water.
- Both phases are heated to about 75 ° C, then the aqueous phase is emulsified in the fat phase with slow stirring. 5% by mass of dye and 1% by mass of blood plasma extract are added to the cream obtained.
- the blood plasma extract means the desalted extract produced by ultrafiltration. All of the products described had an excellent effect and proved the existence of the advantages already explained in practice.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU234884 | 1984-06-19 | ||
| HU234884A HU193290B (en) | 1984-06-19 | 1984-06-19 | Cinditioning cosmetical composition containing blood plasma concentrate as active agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0186681A1 true EP0186681A1 (de) | 1986-07-09 |
Family
ID=10958953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19850902628 Withdrawn EP0186681A1 (de) | 1984-06-19 | 1985-06-19 | Hautpflegemittel und verfahren zu seiner herstellung |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0186681A1 (de) |
| HU (1) | HU193290B (de) |
| WO (1) | WO1986000224A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030044366A1 (en) * | 2001-08-10 | 2003-03-06 | Dole Victoria F. | Skin care composition that changes color upon drying |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR431904A (fr) * | 1911-05-09 | 1911-11-23 | Schaefer De Esparza Caroline | Procédé de préparation de solutions d'albumine pour usages cosmétiques, sans addition d'autres matières |
| GB1038415A (en) * | 1964-04-17 | 1966-08-10 | Curtis Helene Ind Inc | Cosmetic preparations containing albumins |
| BE786890A (de) * | 1971-07-29 | 1973-01-29 | Oreal | |
| FR2160285A1 (en) * | 1971-11-17 | 1973-06-29 | Metzinger Albert | Embryonic serum-based compsn - used as a skin tonic |
| FR2173813B1 (de) * | 1972-03-03 | 1976-07-09 | Orlane | |
| FR2472385A1 (fr) * | 1979-12-27 | 1981-07-03 | Sederma Sa | Nouveaux extraits biologiques utilisables en cosmetologie, et procedes d'obtention de ces extraits |
-
1984
- 1984-06-19 HU HU234884A patent/HU193290B/hu not_active IP Right Cessation
-
1985
- 1985-06-19 WO PCT/HU1985/000037 patent/WO1986000224A1/de not_active Ceased
- 1985-06-19 EP EP19850902628 patent/EP0186681A1/de not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO8600224A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1986000224A1 (fr) | 1986-01-16 |
| HU193290B (en) | 1987-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19860754B4 (de) | Kosmetische Zubereitung | |
| CA1138739A (fr) | Composition demaquillante pour le visage et les yeux | |
| EP0556660B1 (de) | Verwendungen von alpha-Hydroxyfettsäuren | |
| DE2223306C3 (de) | Kosmetische Zubereitung gegen fettiges Aussehen von Haar und Haut und gegen Schuppenbildung | |
| DE69200959T2 (de) | N-acylderivate von aus getreideproteinhydrolysaten gewonnenen aminosäuremischungen und ihre anwendungen. | |
| DE3541008C2 (de) | ||
| CA1132049A (fr) | Composition pour le nettoyage de la peau | |
| DE2722725C2 (de) | ||
| DE69011439T2 (de) | Neue kosmetische Präparate die Chitosan und Glucosamin enthalten. | |
| DE69024370T2 (de) | Hautpräparat zur äusserlichen anwendung | |
| DE69800170T2 (de) | System bestehend aus Phosphonsäurederivate und Metabisulfit zur Stabilisierung von Ascorbinsäure | |
| DE2300443A1 (de) | Hautbehandlungszusammensetzung | |
| EP0186025A2 (de) | Kosmetische Zubereitungen mit Mandel-Proteinhydrolysat | |
| DE3702178A1 (de) | Nicht-ionische polyglycerinaether, diese verbindungen enthaltende mittel und deren verwendung in der kosmetik und in der pharmazie | |
| DE1492121A1 (de) | Zubereitungen zur Herstellung von Koerperpflegemitteln | |
| DE69424690T2 (de) | Methode zur herstellung von kollagen aus cnidarians und entsprechende kosmetische zusammensetzungen | |
| EP0079913B1 (de) | Arencarbonsäure-derivate als antiseborrhoische zusätze für kosmetische mittel | |
| DE2248240A1 (de) | Kosmetische, desodorierende antischwitzgemische | |
| DE69703068T2 (de) | Verwendung von N,N'-Dibenzyl-Äthylendiaminsäure-Derivaten als Depigmentierungsagentien | |
| EP0187147A1 (de) | Präparat zur haar- und nagelpflege und verfahren zu seiner herstellung | |
| WO1998038968A2 (de) | Kosmetisches körperpflegepräparat das honig enthält und verfahren zu seiner herstellung | |
| DE2524297B2 (de) | Kosmetisches Produkt mit Haut zart machender Wirkung | |
| DE2804024A1 (de) | Kosmetischer wirkstoff auf hautproteinbasis | |
| EP0081771A1 (de) | Heterocyclische Verbindungen, Herstellung dieser Verbindungen, kosmetische Mittel, die diese Verbindungen als Wirkstoffe enthalten, sowie Verwendung dieser Mittel zur Pflege des Haares oder der Haut | |
| JPH0520411B2 (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19860210 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| 17Q | First examination report despatched |
Effective date: 19881003 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19890213 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BANETH, PETER Inventor name: LACZKO, ISTVAN Inventor name: CSELOVSKY, JANOSNE Inventor name: VARRO, GYOERGYNE Inventor name: KOVACS, ESZTER Inventor name: GABOR, MIKLOSNE Inventor name: FUELOEP, LASZLONE Inventor name: BASA, ERZSEBET Inventor name: HORVATH, BELA |